- Company Overview for APOLLO THERAPEUTICS NO.2 LLP (OC403442)
- Filing history for APOLLO THERAPEUTICS NO.2 LLP (OC403442)
- People for APOLLO THERAPEUTICS NO.2 LLP (OC403442)
- More for APOLLO THERAPEUTICS NO.2 LLP (OC403442)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
13 Jun 2019 | LLCH02 | Member's details changed for Imperial Innovations Limited on 1 March 2019 | |
20 Dec 2018 | LLCS01 | Confirmation statement made on 14 December 2018 with no updates | |
16 Jul 2018 | AA | Full accounts made up to 31 December 2017 | |
27 Mar 2018 | LLPSC08 | Notification of a person with significant control statement | |
26 Mar 2018 | LLPSC09 | Withdrawal of a person with significant control statement on 26 March 2018 | |
19 Dec 2017 | LLCS01 | Confirmation statement made on 14 December 2017 with no updates | |
18 Dec 2017 | LLCH02 | Member's details changed for Astrazeneca Uk Limited on 17 December 2017 | |
21 Jun 2017 | AA | Full accounts made up to 31 December 2016 | |
19 Dec 2016 | LLCS01 | Confirmation statement made on 14 December 2016 with updates | |
25 May 2016 | LLAD01 | Registered office address changed from 52 Princes Gate Exhibition Road London SW7 2PG United Kingdom to Stevenage Biosciences Catalyst Gunnels Wood Road Stevenage Hertfordshire SG1 2FX on 25 May 2016 | |
03 Feb 2016 | CERTNM |
Company name changed translational research funding LLP\certificate issued on 03/02/16
|
|
15 Dec 2015 | LLIN01 | Incorporation of a limited liability partnership |